中文名稱:奧拉替尼
中文別名:N-二甲基-1-((1R,4R)-4-甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)環己基)甲磺酰胺;奧克西替尼;N-甲基-1-(反式-4-(甲基(7H-吡咯并[2,3-D]嘧啶-4-基)氨基)環己基)甲磺酰胺
英文名稱:Oclacitinib
英文同義詞:PF-03394197 (oclacitinib);Oclacitinib PF-03394197;JAKi;trans-N-Methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-cyclohexanemethanesulfonamide;CyclohexaneMethanesulfonaMide, N-Methyl-4-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-, trans-;N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide;N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide;Oclacitinib
CAS號:1208319-26-9
分子式:C15H23N5O2S
分子量:
規格含量：99%
包裝規格：25kg/桶
用途：奧拉替尼是一種新型Janus激酶（JAK）抑制劑，具有抗過敏相關細胞因子的活性。適用于醫藥類